« Return to News | Awards & Advancement

Medpace Hires Executive to Open Bioanalytical Lab in Fall

Tuesday, August 5, 2008 08:00 AM

Cincinnati-based Medpace, a global contract research organization (CRO), has hired Yong-Xi Li as Executive Director of its new Medpace Bioanalytical Laboratories. This new laboratory is projected to open in fall of 2008 and will complement services provided by other Medpace research facilities, such as Medpace Clinical Pharmacology and Medpace Reference Laboratories.

Dr. Li joins Medpace with a strong background in bioanalytical technology, method development, validation, and sample analysis in support of pharmaceutical development and both preclinical and clinical studies.

At Medpace, Dr. Li will direct operations and activities of the new, advanced mass spectrometry Medpace Bioanalytical Laboratories, including bioanalytical aspects for small and large drug molecules according to GLP and GMP compliances and ICH guidelines.

Dr. Li comes to Medpace from Eurofins Scientific, NJ, where he served as Senior Director, managing its laboratory process and facilitating bioanalytical technology and methods. Prior to his work at Eurofins Scientific, Dr. Li was the Vice President of Ricerca and then the Vice President of XenoBiotics Laboratories, where he led and expanded the bioanalytical laboratories and activities.

Dr. Li arrived in the United States and worked as a senior research scientist under Dr. K.J. Klubende and Dr. B.H. Davis to establish his first bioanalytical laboratory. He went on to do postdoctoral studies in Chemistry at Cornell University, Baker Laboratory, in Ithaca, New York.

“We are excited to have an experienced chemist such as Yong-Xi Li on staff,” said August Troendle, M.D., Medpace’s CEO.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.